Nature's Sunshine Products financials
$12.76−0.55%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $117.0M | $122.9M | $123.8M | $128.3M | $114.8M | $113.2M | $118.2M | $114.6M | $110.6M | $111.0M | $108.9M | $111.2M |
| Gross profit | $86.2M | $90.0M | $89.8M | $94.0M | $82.3M | $81.6M | $85.1M | $81.8M | $78.9M | $79.0M | $78.3M | $81.2M |
| Gross margin | 73.7% | 73.2% | 72.5% | 73.3% | 71.7% | 72.1% | 72.0% | 71.3% | 71.4% | 71.2% | 71.9% | 73.1% |
| Operating income | $5.5M | $9.5M | $5.3M | $9.0M | $4.3M | $6.2M | $4.5M | $5.3M | $5.6M | $4.6M | $5.7M | $5.8M |
| Net income | $3.5M | $5.1M | $4.1M | $5.3M | $5.3M | $4.7M | -$321.0K | $4.3M | $1.3M | $2.3M | $9.0M | $2.8M |
| Net margin | 3.0% | 4.2% | 3.3% | 4.2% | 4.6% | 4.2% | −0.3% | 3.8% | 1.2% | 2.1% | 8.2% | 2.5% |
| Diluted EPS | $0.19 | $0.29 | $0.23 | $0.30 | $0.28 | $0.25 | $-0.02 | $0.23 | $0.07 | $0.12 | $0.47 | $0.15 |
| EBITDA | $8.8M | $12.8M | $8.6M | $12.5M | $7.8M | $9.7M | $8.6M | $8.8M | $9.1M | $7.8M | $8.8M | $9.0M |
| Operating cash flow | $835.0K | -$1.8M | $10.0M | $18.4M | $4.3M | $2.6M | $12.2M | $9.5M | $1.4M | $2.2M | $9.6M | $14.3M |
| Free cash flow | -$1.9M | -$4.3M | $7.7M | $16.7M | $3.0M | $1.5M | $10.0M | $7.8M | -$2.0M | -$1.5M | $8.3M | $9.8M |
| Diluted shares | 18.3M | 17.9M | 18.0M | 18.0M | 19.0M | 18.8M | 19.1M | 18.9M | 19.1M | 19.2M | 19.2M | 19.5M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $82.5M | $87.6M | $93.9M | $95.6M | $81.3M | $86.5M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $259.8M | $261.5M | $261.1M | $264.8M | $254.9M | $252.7M |
| Total liabilities | $90.5M | $94.5M | $99.6M | $98.1M | $91.2M | $85.6M |
| Shareholders' equity | $169.3M | $166.9M | $161.6M | $166.7M | $163.7M | $167.1M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology